Breakthrough T1D: Difference between revisions
Undid revision 848568969 by ElisabethF (talk) this is WP:OR. Please do see your talk page. |
ElisabethF (talk | contribs) |
||
| Line 25: | Line 25: | ||
== Research == |
== Research == |
||
JDRF generally funds research directed to finding a cure, managing the disease, and preventing it.<ref name="JDRF: Mission, Strategy and Priorities (Diabetes Journal)">{{cite web|title=JDRF:Mission, Strategy and Priorities |url=http://diabetes.diabetesjournals.org/content/61/1/30.full|work=Diabetes Journal, January 2012 |accessdate=10 May 2013}}</ref> |
JDRF generally funds research directed to finding a cure, managing the disease, and preventing it.<ref name="JDRF: Mission, Strategy and Priorities (Diabetes Journal)">{{cite web|title=JDRF:Mission, Strategy and Priorities |url=http://diabetes.diabetesjournals.org/content/61/1/30.full|work=Diabetes Journal, January 2012 |accessdate=10 May 2013}}</ref> |
||
In 2017, JDRF provided $79 million (38% of their total income) to T1D scientific research grants. Research grant spending was $110 million (57%) in 2012, $138 million (60%) in 2007, and $108 million (78%) in 2002.<ref>https://projects.propublica.org/nonprofits/organizations/231907729</ref><ref>http://thejdca.org/2018-jdrf-financials</ref> |
|||
[[File:Wikiwikiwikiwiki.jpg|thumb|Research Grant Spending Charts|thumbnail|none|upright=3.0|The images above provide an overview of JDRF research spending from 2001 to 2017.<ref>https://projects.propublica.org/nonprofits/organizations/231907729</ref><ref>http://thejdca.org/2018-jdrf-financials</ref>]] |
|||
In 2017, the JDRF spent $21 million (11% of JDRF’s total revenue) on expenses related to research grant spending (administration costs). Expenses related to research grant spending was $14 million in 2012 (7% of JDRF’s total revenue), and $9 million in 2007 (4%), the most recent year this information was made publicly available. This includes all costs directly related to giving and managing research grants, including salary, bonuses, administration, meetings, etc.<ref>https://projects.propublica.org/nonprofits/organizations/231907729</ref><ref>http://thejdca.org/2018-jdrf-financials</ref> |
|||
In 2005 the board of JDRF committed to supporting work on medical devices to manage blood glucose, known as [[Artificial_pancreas#Medical_equipment|"artifical pancreas'']] technology. The Board was urged to do so by Jeffrey Brewer, who had founded and sold [{Citysearch]] and had become intensely interested in juvenile diabetes and medical devices after his son was diagnosed with the condition.<ref name="Robotic Pancreas">{{cite web|title=Robotic Pancreas: One Man's Quest to Put Millions of Diabetics on Autopilot |url=https://www.wired.com/magazine/2010/04/ff_pancreas/|work=Wired Magazine, April 19, 2010 |accessdate=10 May 2013}}</ref> |
In 2005 the board of JDRF committed to supporting work on medical devices to manage blood glucose, known as [[Artificial_pancreas#Medical_equipment|"artifical pancreas'']] technology. The Board was urged to do so by Jeffrey Brewer, who had founded and sold [{Citysearch]] and had become intensely interested in juvenile diabetes and medical devices after his son was diagnosed with the condition.<ref name="Robotic Pancreas">{{cite web|title=Robotic Pancreas: One Man's Quest to Put Millions of Diabetics on Autopilot |url=https://www.wired.com/magazine/2010/04/ff_pancreas/|work=Wired Magazine, April 19, 2010 |accessdate=10 May 2013}}</ref> |
||
Revision as of 13:52, 1 August 2018
| File:Juvenile Diabetes Research Foundation (logo).png | |
| Founded | May 28, 1970[1] |
|---|---|
| Founder | Lee Ducat, Carol Lurie |
| 23-1907729[2] | |
| Legal status | 501(c)(3) nonprofit organization[3] |
| Location |
|
| Method | Research funding, Political advocacy, Education |
| Subsidiaries | JDRF Theraputics Fund LLC[2] |
Revenue (2016) | $204,355,782[2] |
| Expenses (2016) | $189,479,405[2] |
| Endowment | $7,176,427[2] |
Employees (2015) | 890[2] |
Volunteers (2015) | 300,000[2] |
| Website | jdrf |
Formerly called | Juvenile Diabetes Research Foundation |
.png){kind=link}
JDRF is a nonprofit 501(c)(3) organization that funds type 1 diabetes (T1D) research and advocates for regulation favorable to medical research and that makes it easier to market new medical devices. It was formerly called the Juvenile Diabetes Research Foundation.
Research
JDRF generally funds research directed to finding a cure, managing the disease, and preventing it.[4]
In 2017, JDRF provided $79 million (38% of their total income) to T1D scientific research grants. Research grant spending was $110 million (57%) in 2012, $138 million (60%) in 2007, and $108 million (78%) in 2002.[5][6]
In 2017, the JDRF spent $21 million (11% of JDRF’s total revenue) on expenses related to research grant spending (administration costs). Expenses related to research grant spending was $14 million in 2012 (7% of JDRF’s total revenue), and $9 million in 2007 (4%), the most recent year this information was made publicly available. This includes all costs directly related to giving and managing research grants, including salary, bonuses, administration, meetings, etc.[9][10]
In 2005 the board of JDRF committed to supporting work on medical devices to manage blood glucose, known as "artifical pancreas technology. The Board was urged to do so by Jeffrey Brewer, who had founded and sold [{Citysearch]] and had become intensely interested in juvenile diabetes and medical devices after his son was diagnosed with the condition.[11]
The project brought together academic researchers and medical device companies. The focus was on integrating continuous glucose monitors (CGM's) and insulin pumps via a computerized program that would use blood glucose levels obtained through the CGM to calculate an insulin dosage to be dispensed through the insulin pump.[12][13]
Advocacy
In 2011 the FDA had made it a priority to clarify the requirements for approval for such a closed-loop monitoring and drug delivery device for TID, and in 2011 announced it was preparing draft guidelines. JDRF launched a campaign to influence those guidelines to be lenient.[12]
JDRF has advocated for stem cell research; in a 2004 article in The Wall Street Journal, the authors observed that the JDRF "... has become adept at unleashing an army of hard-to-resist lobbyists -- made up of determined parents and their afflicted children -- on researchers, politicians and potential donors."[14]
See also
- Juvenation
- Taste of Tennis, a donor
References
- ^ "JDRF International". Pennsylvania Department of State. Retrieved September 27, 2017.
- ^ a b c d e f g "Form 990: Return of Organization Exempt from Income Tax". JDRF International. Guidestar. June 30, 2016.
- ^ "JDRF". Exempt Organizations Select Check. Internal Revenue Service. Retrieved September 27, 2017.
- ^ "JDRF:Mission, Strategy and Priorities". Diabetes Journal, January 2012. Retrieved 10 May 2013.
- ^ https://projects.propublica.org/nonprofits/organizations/231907729
- ^ http://thejdca.org/2018-jdrf-financials
- ^ https://projects.propublica.org/nonprofits/organizations/231907729
- ^ http://thejdca.org/2018-jdrf-financials
- ^ https://projects.propublica.org/nonprofits/organizations/231907729
- ^ http://thejdca.org/2018-jdrf-financials
- ^ "Robotic Pancreas: One Man's Quest to Put Millions of Diabetics on Autopilot". Wired Magazine, April 19, 2010. Retrieved 10 May 2013.
- ^ a b Dolgin, E (17 May 2012). "Medical devices: Managed by machine" (PDF). Nature. 485 (7398): S6-8. PMID 22616096.
- ^ "Artificial Pancreas Gives Girl a Vacation from Diabetes". CNN, March 4, 2012. Retrieved 10 May 2013.
- ^ Regalado, A; Waldholz, M (31 March 2004). "Ballot drive puts stem-cell funding in voters' hands. In California, diabetes groups show growing influence as they push for research; big backing from Hollywood". Wall Street journal (Eastern ed.): A1, A12. PMID 15250089.